$CBDL CBD Life Sciences, Inc. (CBDL) Announces Exp
Post# of 1068
(Total Views: 210)
Posted On: 11/09/2022 8:07:32 AM
$CBDL CBD Life Sciences, Inc. (CBDL) Announces Expansion of Product Line
https://www.accesswire.com/724654/cbd-life-sc...oduct-line
SCOTTSDALE, AZ / ACCESSWIRE / November 9, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has developed a product that may aid consumers in many ways around the globe.
Our new PR-X 100MG per tablet supplement has been in development for several months and is finally ready to hit the shelves! This product has been created with all natural ingredients infused with the purest Full-Spectrum CBD Isolate on the market. It is also lab tested for potency and consistency. PR-X is designed for and may help with prostate health, urinary, & hair support. President & CEO Lisa Nelson states "This is a giant step in the right direction for the company as we are trying to always create new products that have never been seen before from any of our competitors. PR-X is expected to boost revenue significantly and we are currently contacting dispensaries & convenient stores around Arizona to push this specific product to the next level in a movement to promote overall health to the max!"
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to receive help from CBD. More updates to come!
https://www.accesswire.com/724654/cbd-life-sc...oduct-line
SCOTTSDALE, AZ / ACCESSWIRE / November 9, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has developed a product that may aid consumers in many ways around the globe.
Our new PR-X 100MG per tablet supplement has been in development for several months and is finally ready to hit the shelves! This product has been created with all natural ingredients infused with the purest Full-Spectrum CBD Isolate on the market. It is also lab tested for potency and consistency. PR-X is designed for and may help with prostate health, urinary, & hair support. President & CEO Lisa Nelson states "This is a giant step in the right direction for the company as we are trying to always create new products that have never been seen before from any of our competitors. PR-X is expected to boost revenue significantly and we are currently contacting dispensaries & convenient stores around Arizona to push this specific product to the next level in a movement to promote overall health to the max!"
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to receive help from CBD. More updates to come!
(0)
(0)CBD Life Sciences Inc. (CBDL) Stock Research Links
Scroll down for more posts ▼